Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

AGL

Angle (AGL)

Angle Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:AGL
DateTimeSourceHeadlineSymbolCompany
17/05/202405:09Alliance NewsAlliance NewsTRADING UPDATES: Bens Creek considers administration; Nexxen inks dealLSE:AGLAngle Plc
16/05/202416:00RNS Non-RegulatoryAngle PLC Study of ovarian cancer CTCs using ParsortixLSE:AGLAngle Plc
03/05/202421:17Alliance NewsAlliance NewsCORRECT: Angle shares up on assay development deal with AstraZenecaLSE:AGLAngle Plc
03/05/202420:50Alliance NewsAlliance NewsAngle shares up on assay development deal with AstraZenacaLSE:AGLAngle Plc
03/05/202416:00RNS Regulatory NewsAngle PLC New commercial agreement with large pharmaLSE:AGLAngle Plc
24/04/202419:32Alliance NewsAlliance NewsAngle shares jump on supplier agreement with with AstraZenecaLSE:AGLAngle Plc
24/04/202416:00RNS Regulatory NewsAngle PLC New commercial agreement with AstraZenecaLSE:AGLAngle Plc
23/04/202401:52Alliance NewsAlliance NewsIN BRIEF: Angle granted patents in US and Europe for Cellkeep slideLSE:AGLAngle Plc
22/04/202416:00RNS Regulatory NewsAngle PLC US and EU patents for innovative CellKeep™ slideLSE:AGLAngle Plc
08/04/202416:00RNS Non-RegulatoryAngle PLC Parsortix HER2 assay showcased at AACR 2024LSE:AGLAngle Plc
22/03/202418:00RNS Non-RegulatoryAngle PLC Parsortix at European breast cancer conferenceLSE:AGLAngle Plc
23/01/202405:03Alliance NewsAlliance NewsIN BRIEF: Angle highlights supportive data for DNA analysis toolLSE:AGLAngle Plc
22/01/202418:00RNS Non-RegulatoryAngle PLC Potential utility in precision oncologyLSE:AGLAngle Plc
10/01/202423:57UK RegulatoryAngle PLC Standard form for notification of major holdingsLSE:AGLAngle Plc
04/01/202423:19Alliance NewsAlliance NewsAngle shares soar following "breakthrough" cancer diagnostics resultsLSE:AGLAngle Plc
04/01/202420:10Dow Jones NewsAngle PLC Shares Rise on Cancer Patient Blood Sample AnalysisLSE:AGLAngle Plc
04/01/202418:00UK RegulatoryAngle PLC Breakthrough clinical resultsLSE:AGLAngle Plc
02/01/202419:51Alliance NewsAlliance NewsIN BRIEF: Angle teams with Japan's Eisai in breast cancer drug trialLSE:AGLAngle Plc
02/01/202418:00UK RegulatoryAngle PLC Contract announcement with Eisai Inc.LSE:AGLAngle Plc
12/12/202307:44Alliance NewsAlliance NewsTRADING UPDATES: Ondine Biomedical raises GBP2.9 million via placingLSE:AGLAngle Plc
11/12/202318:00RNS Non-RegulatoryAngle PLC Parsortix unlocks opportunities for drug discoveryLSE:AGLAngle Plc
11/12/202318:00UK RegulatoryAngle PLC Broker AnnouncementLSE:AGLAngle Plc
05/12/202322:50Alliance NewsAlliance NewsIN BRIEF: Angle launches diagnostic kit at cancer symposiumLSE:AGLAngle Plc
05/12/202318:00RNS Non-RegulatoryAngle PLC ANGLE launches Portrait+ CTC kit at SABCSLSE:AGLAngle Plc
10/11/202301:29Alliance NewsAlliance NewsAngle says build up of revenue slower than hoped; launches testLSE:AGLAngle Plc
09/11/202318:00UK RegulatoryAngle PLC Trading and business updateLSE:AGLAngle Plc
09/11/202318:00RNS Non-RegulatoryAngle PLC Launch of PD-L1 test to support cancer studiesLSE:AGLAngle Plc
26/10/202303:28Alliance NewsAlliance NewsTRADING UPDATES: Franchise Brands trading in line; Tribe secures loanLSE:AGLAngle Plc
25/10/202317:00RNS Non-RegulatoryAngle PLC Supporting characterisation of CTCs in HNSCCLSE:AGLAngle Plc
03/10/202323:02Alliance NewsAlliance NewsAngle hails study which shows Parsortix outperforming lab standardLSE:AGLAngle Plc
 Showing the most relevant articles for your search:LSE:AGL